Facebook's management is bullish long-term but admits 2018 might be a tricky year. ANI Pharma gets one step closer to manufacturing a blockbuster drug and Target is on deck for earnings this week. Read More
Linda McDonough is a veteran hedge fund analyst who loves to break down company financial statements and identify market inefficiencies to uncover big opportunities. She believes in a boots-on-the-ground approach that includes surveying customers, interviewing company executives, or doing whatever it takes to see what others don't.
She's now brought her experience as a hedge fund analyst to subscribers of her Profit Catalyst Alert service. Her system identifies small- and mid-cap stocks that are about to move due to catalytic events that few others can identify...until it's too late. These events often times result in massive gains for her followers.
Analyst Articles
Facebook has dropped partly due to a less-than-exuberant management presentation and partly due to the market malaise. Either way, book this fabulous one-week gain. Read More
Packages are taking longer to arrive on your doorstep. Many companies are complaining their profits are getting jammed due to higher freight expenses. How to find the companies that will benefit from these increased costs. Read More
It's been a rough two-weeks for my option trade suggestions. A bit of thought regarding those positions and news coming this week on put position Facebook. Read More
It may sound like heresy to short market darling Facebook but it looks like it's hitting some major stumbling blocks. I expect the stock to stumble during its upcoming February presentation at a significant investor conference. Read More
Instacart's new infusion of cash values the company 24% higher than last year. How and why grocery delivery companies are the most popular ones on the block and how to prosper from this giant trend. Read More
Carbonite enjoyed an excellent week as investors celebrated its purchase of competitor Mozy. Vulcan got stuck in the mud (or cement) due to increased expenses but is optimistic about 2018 and a bit about how to win regardless of the market direction. Read More
Emergent BioSolutions has been zigzagging with the market. I still like the stock but know how fickle investors can be with healthcare stocks. Book this solid gain and we'll revisit the name for more trades in the future. Read More
Target's been knocking it out of the park with its refreshed inventory while Big Lots is hitting the wall on furniture sales. Target's recent introduction of popular Casper mattresses will crunch Big Lots' already crunched furniture sales. Both report earnings in the next four weeks. Read More
The mainstream media would have you believe the bears were celebrating during last week's market meltdown. But that's not entirely true. How fast and furious moves in the market can hurt those grizzly short sellers. Read More